-+ 0.00%
-+ 0.00%
-+ 0.00%

Silexion Therapeutics Reports Strong Preclinical Tumor Inhibition With SIL204 in KRAS-Mutated Cancers

Reuters·01/06/2026 12:30:09

Please log in to view news